Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03441113
Title Extended Access of Momelotinib in Adults With Myelofibrosis
Recruitment Enrolling by invitation
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sierra Oncology, Inc.
Indications

myelofibrosis

Therapies

Momelotinib

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUT


No variant requirements are available.